≡ Menu


The problem with the lack of diversity in the life sciences industry is more severe than people perhaps imagined according to new research conducted by the Epsen Fuller Group earlier this year. Only 12.7% and 8.3% of directorships of small to micro pharma, medical devices and bio tech companies are women. The research also shows that there’s been little progress since 2000 in decreasing racial disparities for interest and aptitude in STEM subjects.

[continue reading…]